Browsing by Subject Resistance
Showing results 1 to 5 of 5
| Preview | Issue Date | Title | Author(s) |
| 25-Jun-2008 | ERCC1 expression and RAD51B activity correlate with cell cycle response to platinum drug treatment not DNA repair | Stordal, Britta; Davey, Ross; Bill Walsh Cancer Research Laboratories |
| 2007 | Oxaliplatin for the treatment of cisplatin-resistant cancer: a systematic review | Stordal, Britta; Pavlakis, Nick; Davey, Ross; Bill Walsh Cancer Research Laboratories |
| 2007 | A systematic review of platinum and taxane resistance from bench to clinic: an inverse relationship | Stordal, Britta; Pavlakis, Nick; Davey, Ross; Bill Walsh Cancer Research Laboratories |
| 2009 | Treating cisplatin-resistant cancer: a systematic analysis of oxaliplatin or paclitaxel salvage chemotherapy. | Stordal, Britta; Pavlakis, Nick; Davey, Ross; Bill Walsh Cancer Research Laboratories |
| 2007 | Understanding cisplatin resistance using cellular models | Stordal, Britta; Davey, Mary; Bill Walsh Cancer Research Laboratories |
Showing results 1 to 5 of 5